Dr David Jefferys is Senior Vice President for Global Regulatory, Government Relations, Public Affairs and Patient Safety (EMEA, Russia and Australasia) at Eisai. After qualifying, he worked in clinical and academic medicine before spending 20 years as a senior regulator for both medicines and medical devices.
He was executive director of the UK Medicines Control Agency, CEO and Director of the MDA and joint CEO of the MHRA. He was involved in the establishment of the European Medicines Agency, is a CPMP/CHMP member and Chair of the MRFG and PER scheme. For the last ten years he has worked in industry and chairs several key committees for ABPI, EFPIA and IFPMA.
Training format
Topic
Live online
This one-day workshop aims to give all the key information necessary to understand the regulation of medical devices and diagnostics and to appreciate the key differences from pharmaceutical regulation.
Live online
This course will provide an excellent opportunity to hear the latest developments from regulatory experts, and enable participants to discuss the implications of the regulations on working practices and the potential impact on future regulatory strategies.
Live online
Gain practical guidance on the complex regulatory landscapes of EU and FDA for drug/device & device/drug combination products in this comprehensive course.
Cookies: we use cookies to deliver the best experience to you and to help us understand our customers.
We set the following types of cookies; please set your preference as to which you consent to accepting:
Read our cookie policy
These cookies are essential to correct operation of the website, such as allowing you to log in and purchase. They are used only on this site.
We use Google Analytics to allow us to better understand the type of visitors to our site and their activity. Enabling this should not shape or alter your browsing experience on other websites.
Marketing cookies help us to be more targeted with our online advertising to deliver more relevant content. Enabling this may make you more likely to see adverts from us on other websites.